Posts by: Iqra Mumal

News

The level of damage present in the DNA inside the cell nucleus — called nuclear DNA — correlates with disease duration and functional capacity in patients with Huntington’s disease, suggesting its potential ... Read more

July 5, 2018July 5, 2018

Skyhawk, Celgene Partner to Develop Small Molecule Treatments for Huntington’s, Other Neurological Diseases

Leber's hereditary optic neuropathy, News

Skyhawk Therapeutics and Celgene have entered into a five-year global partnership to use Skyhawk’s STAR* technology platform to discover, advance, and commercialize new small-molecule therapies to treat patients with neurological ... Read more

March 27, 2018March 27, 2018

Targeting Enzyme to Reduce Mutant Protein Levels May Be New Strategy to Fight Huntington’s, Study Says

News

Blocking an enzyme called PIP4Ky has the ability to reduce levels of mutant huntingtin protein and clear toxic aggregates of the protein, suggesting a potentially effective therapeutic strategy against ... Read more

February 22, 2018February 22, 2018

Huntington’s Disease May Start Very Early in Embryo, Research Reveals

News

Huntington’s symptoms may be a late manifestation of a disease that begins much earlier in embryonic development, according to a recent study. The research, “Chromosomal instability during neurogenesis in ... Read more

August 24, 2017August 24, 2017

New CRISPR-Cas9 Technique Corrects Defects Linked to Huntington’s, UCSD Study Suggests

News

A new version of the CRISPR-Cas9 gene editing technique designed to target RNA molecules can fix the underlying cause of Huntington’s disease and similar disorders, say researchers at the ... Read more

June 22, 2017June 22, 2017

Researchers Identify Variant in MSH3 Gene Related to Huntington’s Progression

News

Researchers have identified a variant in the gene MSH3 that is linked with Huntington’s disease (HD) progression. The study, “Identification of genetic variants associated with Huntington’s disease progression: a ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Damage to Nuclear DNA Shown to Correlate with Huntington’s Duration, Patient’s Ability to Function

Skyhawk, Celgene Partner to Develop Small Molecule Treatments for Huntington’s, Other Neurological Diseases

Targeting Enzyme to Reduce Mutant Protein Levels May Be New Strategy to Fight Huntington’s, Study Says

Huntington’s Disease May Start Very Early in Embryo, Research Reveals

New CRISPR-Cas9 Technique Corrects Defects Linked to Huntington’s, UCSD Study Suggests

Researchers Identify Variant in MSH3 Gene Related to Huntington’s Progression

Pin It on Pinterest